BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Aticaprant readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Aticaprant\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07615426-9459@assetmemo.bio
DTSTAMP:20261121T004451Z
DTSTART;VALUE=DATE:20270621
DTEND;VALUE=DATE:20270622
SUMMARY:Aticaprant: Phase 1 readout est. (NCT07615426)
DESCRIPTION:Aticaprant\, phase 1\, Schizophrenia.\nStudy: A Study of the Fe
 asibility\, Safety and Tolerability of Aticaprant as Adjunctive Treatment 
 in Participants With Schizophrenia\nEstimated primary completion: 21 June 
 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout date
 \, and it can move.\nDrug page: https://assetmemo.bio/drug/aticaprant#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07615426
URL:https://assetmemo.bio/drug/aticaprant#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
